IE
ACUR

Israel Englander’s Acura Pharmaceuticals ACUR Stock Holding History

Israel Englander’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,878
Closed -$28K – 4159
2014
Q1 		$28K Buy
+3,878
New +$33.7K ﹤0.01% 3378

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $692M AUM 5% 1-Year Est. Return

Israel Englander's ACUR Position: Q2 2014 in Review

Israel Englander sold out of Acura Pharmaceuticals (ACUR) in Q2 2014, closing a stake of 3,878 shares — an estimated $28K sold.

Israel Englander first reported a position in ACUR in Q1 2014 and held it in 1 quarter. The position peaked at $28K in Q1 2014. 33 funds tracked by Wall St. Rank hold ACUR as of Q2 2014.

  • Israel Englander reported no remaining Acura Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Israel Englander sold 3,878 Acura Pharmaceuticals shares in Q2 2014, an estimated $28K.
  • Israel Englander first reported a position in Acura Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Israel Englander's Acura Pharmaceuticals position peaked at $28K in Q1 2014.
  • 33 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2014.

Based on Millennium Management's 13F filing for Q2 2014, filed 14 Aug 2014.